Ammonia sorbent development for on-board H2 purification

Autor: Allen Murray, Richard Chahine, Bart A. van Hassel, Daniel Cossement, Jagadeswara R. Karra, Salvatore Saita, Daniel Goberman, Jose Santana

Publikováno v: Separation and Purification Technology. 142:215-226

The application of chemical hydrides (e.g. ammonia borane) and amide-based hydrogen storage materials would benefit from an effective means to remove ammonia, which is an impurity that is detrimental to the performance of a PEM fuel cell. One option

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28c927950ece417dd7192663ea611b18
https://doi.org/10.1016/j.seppur.2014.12.009

Endoscopic stenting for double bronco-pleural fistula after lobectomy

Autor: Salvatore Bellofiore, Alberto Terminella, Carmelo Riscica Lizzio, Ignazio Vasta, Giacomo Cusumano, Salvatore Saita

Publikováno v: Asian cardiovascularthoracic annals. 23(8)

Bronchial fistula is one of the most serious complications after pulmonary resection. It presents a challenge in terms of treatment, with a high risk of perioperative mortality. We describe a patient who underwent a right upper lobectomy and systemat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::653d6726b3f3316c9d1c91aa42e5c0cd
https://pubmed.ncbi.nlm.nih.gov/25931566

Tumours of the thymus: a cohort study of prognostic factors from the European Society of Thoracic Surgeons database

Autor: Andrew G Nicholson, Nuria M. Novoa, Moishe Liberman, Alex Arame, Christophoros N. Foroulis, Federico Venuta, David Gómez de Antonio, Frank C. Detterbeck, Marco Anile, Majed Refai, AlKattan Khaled, Wojciech Zurek, Dirk Van Raemdonck, Geoffrey Brioude, Pascal Thomas, Maurizio Mancuso, Mario Nosotti, Marco Scarci, Enrico Ruffini, Robert J. Cerfolio, Alessandro Brunelli, Andrea Evangelista, Eric Lim, Bernhard Moser, Alberto Terzi, Caterina Casadio, Loic Lang-Lazdunski, Pier Luigi Filosso, Alper Toker, Hans Van Veer, Paolo Carbognani, Walter Weder, Luca Voltolini, Giovanni Donati, Nasser K. Altorki, Cengiz Gebitekin, Salvatore Saita, Erino A. Rendina, Alberto Oliaro, Gaetano Rocco, Jan Schutzner, Cosimo Lequaglie, Shaf Keshavjee, Kemp H. Kernstine

OBJECTIVES: A retrospective database was developed by the European Society of Thoracic Surgeons, collecting patients submitted to surgery for thymic tumours to analyse clinico-pathological prognostic predictors. METHODS: A total of 2151 incident case

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e91d958393ed360be1255061618505c3
https://europepmc.org/articles/PMC4155438/

A three-drug induction chemotherapy with gemcitabine, carboplatin, and paclitaxel for stage III non-small cell lung cancer

Autor: Alberto Terminella, Salvatore Saita, Antonio Basile, Giuseppe Luigi Banna, Francesco Marletta, Filippo Fraggetta, Massimo Ippolito, Helga Lipari, Orazio Ezio Urso, Marina Vaglica, Maurizio Nicolosi

Publikováno v: Medical oncology (Northwood, London, England). 30(2)

The aim of the study is to evaluate the efficacy and safety of a three-drug chemotherapy regimen including gemcitabine, carboplatin, and paclitaxel as induction therapy in clinical stage III non-small cell lung cancer (NSCLC). Patients aged 18-75 yea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeca3dc1b4cb37fe5adede9d414789e9
https://pubmed.ncbi.nlm.nih.gov/23512427

CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases

Autor: Sabrina Paratore, Sebastiano Cavallaro, M. D'Arrigo, Letizia Lucenti, Giuseppe Luigi Banna, Rosario Iemmolo, Rosario Cunsolo, Domenico Bellia, Calogero Buscarino, Helga Lipari, Salvatore Saita

Publikováno v: Disease markers. Section A, Cancer biomarkers
info:cnr-pdr/source/autori:Paratore, Sabrina; Banna, Giuseppe Luigi; D'Arrigo, Maria; Saita, Salvatore; Iemmolo, Rosario; Lucenti, Letizia; Bellia, Domenico; Lipari, Helga; Buscarino, Calogero; Cunsolo, Rosario; Cavallaro, Sebastiano/titolo:CXCR4 and CXCL12 immunoreactivities differentiate primary non-small-cell lung cancer with or without brain metastases/doi:10.3233%2FCBM-2011-0232/rivista:Disease markers. Section A, Cancer biomarkers (Print)/anno:2011/pagina_da:79/pagina_a:89/intervallo_pagine:79–89/volume:10

Synchronous or metachronous brain metastases (BMs) occur in about 33% of patients affected by non-small-cell lung cancer (NSCLC). To date, no reliable biological marker is able to identify patients who will develop BMs. In the present study, using a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a42ff0c93fc73b92f264a0434005fec
http://www.cnr.it/prodotto/i/303122